|
|
Article: Total Nutraceutical Solutions Enters Into Agreement With Model Biosystems to Test Proprietary Mushroom Compounds in Suppressing Alzeheimer's Disease.
- Article from:
- Biotech Week
- Article date:
- November 18, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Total Nutraceutical Solutions, Inc. (TNS) (OTCBB:TNUS), announced that the company has started evaluating several proprietary mushroom compounds for activity in controlling the development of Alzheimer's Disease (AD). TNS was informed by Model Biosystems, Inc. (MBS), San Clemente, CA, that a recent experiment in Drosophila melanogaster flies (Drosophila) showed that certain TNS proprietary mushrooms had unusual anti-inflammatory activity. MBS was of the opinion that TNS should evaluate these mushroom samples in a special MBS biologic model for Alzheimer's disease (AD). This proprietary AD model uses a genetic mutant of Drosophila that was developed in the laboratory of ...
Related newspaper, magazine, and journal articles:
|
|
Article: Total Nutraceutical Solutions Receives ...
Business Wire;
June 9, 2009 ;
700+ words
... ... STEVENSON, Wash. -- Total Nutraceutical Solutions, Inc. (OTCBB:TNUS ... technology controlled by Total Nutraceutical Solutions, Inc. (TNS ... securities laws. About Total Nutraceutical Solutions, Inc: Total Nutraceutical ...
|
|